侧隧道Fontan术后患者迟发房内折返性心动过速及预防性冷冻消融的预防作用
单中心回顾性队列研究纳入1988至2003年接受侧隧道Fontan手术的130例患者,其中30例接受预防性冷冻消融,中位随访23.6年。14例(10.8%)发生房内折返性心动过速,均未接受预防性冷冻消融;预防性冷冻消融对迟发房内折返性心动过速(P<.0001)和心血管死亡(P<.0001)具有保护作用。
要点
- 130例侧隧道Fontan患者中14例(10.8%)发生迟发房内折返性心动过速,均未接受预防性冷冻消融。
- 预防性冷冻消融组无迟发房内折返性心动过速发生,中位随访22.9年。
- 预防性冷冻消融对迟发房内折返性心动过速和心血管死亡均有保护作用(P<.0001)。
核心结论
- 接受预防性冷冻消融的患者在中位随访22.9年期间均未发生迟发房内折返性心动过速。
- 本研究表明预防性冷冻消融能有效预防侧隧道Fontan术后患者迟发房内折返性心动过速和心血管死亡。
研究设计与样本
- 单中心回顾性队列研究,纳入1988年至2003年间接受侧隧道Fontan手术的患者。
- 共130例患者,其中30例接受预防性冷冻消融,中位随访23.6年(四分位距17.7-26.5)。
- 采用单因素和多因素竞争风险回归模型分析预防性冷冻消融及协变量与迟发房内折返性心动过速、全因死亡和心血管死亡的关联。
主要发现
- 14例患者(10.8%)发生房内折返性心动过速,均未接受预防性冷冻消融。
- Fontan手术至房内折返性心动过速发生的中位时间为17.2年(四分位距11.1-23.1)。
- 预防性冷冻消融对迟发房内折返性心动过速有保护作用(P<.0001)。
- 预防性冷冻消融对心血管死亡有保护作用(P<.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intra-atrial reentrant tachycardia is an important late-onset complication in patients undergoing the Fontan procedure. However, the protective effects of prophylactic cryoablation against late-onset intra-atrial reentrant tachycardia are unclear. This study investigated the late development of intra-atrial reentrant tachycardia in patients undergoing the lateral tunnel Fontan procedure and the role of prophylactic cryoablation. METHODS: This was a single-center retrospective cohort study of patients who underwent the lateral tunnel Fontan procedure between 1988 and 2003. Univariate and multivariable competing risks regression models were used to determine the associations of prophylactic cryoablation and covariates with the outcomes of interest: late-onset intra-atrial reentrant tachycardia, all-cause mortality, and cardiovascular mortality. RESULTS: In total, 130 patients who underwent the lateral tunnel Fontan procedure, 30 of whom had undergone prophylactic cryoablation, were included in this study and followed up for a median of 23.6 years (interquartile range, 17.7-26.5). Intra-atrial reentrant tachycardia was identified in 14 patients (10.8%), none of whom underwent prophylactic cryoablation. The median Fontan-to-intra-atrial reentrant tachycardia time was 17.2 years (interquartile range, 11.1-23.1). Prophylactic cryoablation was protective against late-onset intra-atrial reentrant tachycardia (P < .0001) and cardiovascular mortality (P < .0001) in the type 3 test. CONCLUSIONS: None of the patients who underwent prophylactic cryoablation developed late-onset intra-atrial reentrant tachycardia during a median follow-up time of 22.9 years. Our study demonstrated that prophylactic cryoablation was effective in preventing late-onset intra-atrial reentrant tachycardia and cardiovascular mortality in patients undergoing the lateral tunnel Fontan.
引用
- Ryu YH, Song MK, Lee SY, et al. Late development of intra-atrial reentrant tachycardia in lateral tunnel Fontan patients and the preventive role of prophylactic cryoablation. J Thorac Cardiovasc Surg. 2023. PMID: 37992960. doi:10.1016/j.jtcvs.2023.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。